Compare TLX & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | HCC |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | N/A | 2017 |
| Metric | TLX | HCC |
|---|---|---|
| Price | $8.05 | $89.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $21.00 | ★ $74.50 |
| AVG Volume (30 Days) | 169.8K | ★ 715.6K |
| Earning Date | 01-15-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.04 | ★ 0.67 |
| Revenue | $664,225,558.00 | ★ $1,224,320,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $47.09 |
| P/E Ratio | $249.18 | ★ $133.32 |
| Revenue Growth | ★ 55.35 | N/A |
| 52 Week Low | $7.72 | $38.00 |
| 52 Week High | $30.36 | $89.90 |
| Indicator | TLX | HCC |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 70.08 |
| Support Level | $7.72 | $78.00 |
| Resistance Level | $8.22 | $89.90 |
| Average True Range (ATR) | 0.25 | 3.12 |
| MACD | -0.07 | 0.32 |
| Stochastic Oscillator | 13.42 | 92.31 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.